Investing.com -- 标普全球评级 (S&P Global Ratings)将McKesson Corp.的评级展望从稳定上调至正面，同时维持其"BBB+"评级。此次展望调整基于该公司美国制药业务部门和处方技术业务的预期增长。预计这些增长将产生强劲的自由现金流，并使公司杠杆率保持在2倍以下。

Q3 2025 Management View Revenue for the quarter grew 18% to $95.3B, with adjusted operating profit increasing 16% to $1.5B. CEO Brian Tyler highlighted strong performance across the U.S.

McKesson inked a deal to buy a controlling interest in Prism Vision Holdings, as it also logged higher profit and revenue in its fiscal third quarter. The drug distributor said Wednesday that it ...

Based on our third quarter performance, we are raising and narrowing our guidance range for fiscal 2025 Adjusted Earnings per Diluted Share to $32.55 to $32.95. We are also pleased to announce the ...

McKesson posted adjusted earnings per share of $8.03 for the quarter ended December 31, 2024, missing the analyst consensus of $8.27. Revenue came in at $95.29 billion, up 18% YoY but below the $95.77 ...

MCK is set to acquire a controlling stake in PRISM Vision Holdings, aiming to expand its specialty care capabilities and strengthen its leadership in eye health solutions across the United States.

McKesson said it will acquire an 80% interest in the provider of general ophthalmology and retina management services. PRISM ...

Luke Tuttle, who's held roles at industry giants including Experian and Klarna, will lead MoneyGram's product development and ...

McKesson Corporation has signed a definitive agreement to acquire an 80% stake in Prism Vision Holdings from Quad-C for approximately $850 million.

Irving-based McKesson (NYSE: MCK) announced on Feb. 4 an agreement to buy an 80% controlling interest in New Providence, New ...